It was conversed with a Federal Court by Samsung that the patent office of the United States had discarded all of the claims of the Apple Inc.(NASDAQ:AAPL) patent. This was specified by a Journal as the foundation of the case by Apple Inc. (NASDAQ:AAPL) in opposition to Samsung.<\/p>\n
In the month of October, it was cautiously concluded by the Patent and Trademark Office that all the 20 claims of an additional Apple Inc. (NASDAQ:AAPL) patent, were not valid. Before two weeks, the “touchscreen heuristics” patent was nullified by the Patent and Trademark Office.<\/p>\n
All of the three rulings are derived from the amendments in the patent law of the United States that was passed by the Congress in the previous year as a section to the Leahy-Smith American Invents Act.<\/p>\n
Major stipulations of the Leahy-Smith American Invents Act makes it considerably simpler to question a patent even after it has received approval. This can be done for $17,750 to be paid as the filing fee. Anyone can put forward a request to the Patent Office for it to act on a review of the patent after its approval on grounds of invalidity.<\/p>\n
Also, the modified law puts Patent office in a difficult situation as it cannot reject the review. In all of the three patents, an investigator of patent established to re-visit the claims by Apple Inc. (NASDAQ:AAPL) basis latest protestation and concluded that a draft of the case was possible.<\/p>\n
Now the load falls on Apple Inc. (NASDAQ:AAPL) and it is expected to defend all what it claims.<\/p>\n
The most important point is that with the lowering of the barriers and much of discussion on the Apple Inc. (NASDAQ:AAPL)\u2019s claims being valid, there are enormous challenges that will be emerging in the future.<\/p>\n
The proceedings in the review after the approval being received, is quite similar to the ex parte reexaminations as far as their goal is concerned. These are both utilized for a patent to be challenged after its issuance. Numerous mechanisms are now available to be able to challenge or oppose a patent after its approval. The most commonly used and the know means are ex parte reexamination, review of covered business method patents, post grant review and inter partes review<\/p>\n
All of the patents by Apple Inc. (NASDAQ:AAPL) were confronted with the request called ex parte reexamination and was filed in May.<\/p>\n
Shares of Apple Inc. (NASDAQ:AAPL) closed at $521.73<\/p>\n","protected":false},"excerpt":{"rendered":"
It was conversed with a Federal Court by Samsung that the patent office of the United States had discarded all of the claims of the […]<\/p>\n","protected":false},"author":15,"featured_media":5139,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[1483],"tags":[1002],"stock_ticker":[],"class_list":["post-5138","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-hot-news","tag-nasdaqaapl","entry"],"acf":[],"yoast_head":"\n